The Valley Desk

NCT07490301 · Interventional trial

A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma

Overall registry status Recruiting

Phase 2 · Phase 3

Conditions Metastatic Pancreatic Ductal Adenocarcinoma, PDAC

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov